The Australian private equity market is set to play a pivotal role in shaping the country’s economic future. In our inaugural Australia Private Equity Value Creation report, we deep dive into how Australian-focused PE funds and operators are performing and how their strategies compare globally.
As biologics face a record-breaking patent cliff, the anticipated biosimilar wave may be more of a ripple than a wave. To thrive, life sciences firms must shift from solely pursuing speed to mastering precision.
Alvarez & Marsal's new Swiss Debt Restructuring Moratorium Survey reveals the number of cases peaked once again in 2024, building on the increased utilization already observed in 2023.